EXEL: 伊克力西斯

EXEL新闻

• 17:35 9 Health Care Stocks Whale Activity In Today’s Session
• 13:45 Arcus Reverses Course, Surging On Its Merck-Rivaling Cancer Reveal
• 13:11 花旗维持对 Exelixis 的“跑赢大盘”评级，将目标价上调至 65 美元
• 13:11 Citizens Maintains Market Outperform on Exelixis, Raises Price Target to $65
• 12:45 Why Exelixis (EXEL) is a Top Growth Stock for the Long-Term
• 15:10 Why Exelixis (EXEL) is Poised to Beat Earnings Estimates Again
• 12:09 Stock Market Today: Nasdaq Hit As Inflation Runs Hot; Dell Slumps, But These Biotech Names Gain (Live Coverage)
• 11:30 Biotech Stocks To Watch: Regeneron Partner Has Breakout In Sight
• 14:39 RBC Capital维持对Exelixis的行业表现评级，将目标价上调至51美元
• 14:39 RBC Capital Maintains Sector Perform on Exelixis, Raises Price Target to $51
• 14:48 RBC资本维持对Exelixis的行业表现评级，将目标价下调至45美元
• 14:48 RBC Capital Maintains Sector Perform on Exelixis, Lowers Price Target to $45
• 12:40 Here's Why Exelixis (EXEL) is a Strong Value Stock
• 12:00 These IBD 50 Stocks Are Stalled. That Could Be A Good Thing.
• 12:45 Exelixis (EXEL) is a Top-Ranked Growth Stock: Should You Buy?
• 15:48 Could Zanzalintinib's FDA Delay Affect Exelixis' Growth Plans?
• 13:50 Here's Why Exelixis (EXEL) is a Strong Momentum Stock
• 04:53 How Is Incyte’s Stock Performance Compared to Other Biotech Stocks?
• 12:53 Alpha Teknova (TKNO) Moves 7.1% Higher: Will This Strength Last?
• 13:40 Why Exelixis (EXEL) is a Top Value Stock for the Long-Term
• 11:59 Stock Market Today: Dow Pressured As Yields Hit 5%; Strategy Soars As Bitcoin Price Tops $80,500 (Live Coverage)
• 22:32 Rubrik Stock, Palantir, CrowdStrike Among 21 New Names On IBD Watchlists
• 13:45 Here's Why Exelixis (EXEL) is a Strong Growth Stock
• 05:15 Exelixis: The FDA Delay Costs Less Than The Market Thinks (NASDAQ:EXEL)